Interactive Financial Charts Not Available

Steris plc (STE) | Financial Analysis & Statements

Steris plc | Large-cap | Healthcare

$248.39

0.03%

Steris plc vs Abbott Laboratories Steris plc vs Boston Scientific Steris plc vs Stryker Steris plc vs Medtronic plc Steris plc vs Edwards Lifesciences Steris plc vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 1.5B

Gross Profit 641.2M 43.31%

Operating Income 279.6M 18.89%

Net Income 146.1M 9.87%

Balance Sheet Metrics

Total Assets 10.1B

Total Liabilities 3.5B

Shareholders Equity 6.6B

Debt to Equity 0.53

Cash Flow Metrics

Operating Cash Flow 203.7M

Free Cash Flow 189.9M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Steris plc Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue i	5.5B	5.1B	4.5B	4.2B	3.1B
Cost of Goods Sold i	3.1B	2.9B	2.6B	2.3B	1.8B
Gross Profit i	2.4B	2.2B	2.0B	1.9B	1.3B
Gross Margin % i	44.0%	43.2%	43.7%	44.6%	43.2%
Operating Expenses
Research & Development i	107.6M	103.7M	98.5M	86.7M	66.3M
Selling, General & Administrative i	1.3B	1.3B	1.1B	1.3B	731.3M
Other Operating Expenses i	-	-	-	-	-
Total Operating Expenses i	1.4B	1.4B	1.2B	1.4B	797.6M
Operating Income i	960.8M	862.2M	791.6M	477.9M	545.5M
Operating Margin % i	17.6%	16.8%	17.5%	11.3%	17.6%
Non-Operating Items
Interest Income i	8.4M	11.0M	-	6.3M	6.3M
Interest Expense i	86.3M	144.4M	110.8M	89.5M	37.2M
Other Non-Operating Income	-86.8M	-26.0M	-485.0K	-27.9M	2.9M
Pre-tax Income i	796.2M	702.8M	680.3M	366.8M	517.5M
Income Tax i	184.6M	149.5M	124.1M	82.3M	120.7M
Effective Tax Rate % i	23.2%	21.3%	18.2%	22.4%	23.3%
Net Income i	616.1M	380.1M	105.8M	242.9M	396.9M
Net Margin % i	11.3%	7.4%	2.3%	5.8%	12.8%
Key Metrics
EBITDA i	1.4B	1.4B	1.3B	1.0B	771.0M
EPS (Basic) i	$6.24	$3.83	$1.07	$2.50	$4.66
EPS (Diluted) i	$6.20	$3.81	$1.07	$2.48	$4.63
Basic Shares Outstanding i	98575000	98787000	99706000	97535000	85203000
Diluted Shares Outstanding i	98575000	98787000	99706000	97535000	85203000

Income Statement Trend

Steris plc Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets
Cash & Equivalents i	171.7M	207.0M	208.4M	348.3M	220.5M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	1.0B	1.0B	865.0M	799.0M	609.4M
Inventory i	581.3M	674.5M	604.4M	575.0M	315.1M
Other Current Assets	203.8M	174.3M	176.1M	156.6M	66.8M
Total Current Assets i	2.0B	2.9B	2.0B	1.9B	1.2B
Non-Current Assets
Property, Plant & Equipment i	1.2B	1.1B	1.0B	1.0B	909.0M
Goodwill i	10.0B	10.3B	9.8B	12.1B	7.0B
Intangible Assets i	1.9B	2.1B	2.1B	3.3B	898.4M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	83.0M	66.2M	1.1B	70.7M	52.7M
Total Non-Current Assets i	8.1B	8.2B	8.8B	9.5B	5.4B
Total Assets i	10.1B	11.1B	10.8B	11.4B	6.6B
Liabilities
Current Liabilities
Accounts Payable i	280.8M	251.7M	264.2M	225.7M	157.0M
Short-term Debt i	159.2M	117.2M	90.1M	179.3M	22.8M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	238.7M	239.7M	201.4M	129.8M	112.0M
Total Current Liabilities i	1.0B	931.1M	861.8M	922.2M	577.9M
Non-Current Liabilities
Long-term Debt i	2.0B	3.3B	3.2B	3.1B	1.8B
Deferred Tax Liabilities i	403.7M	479.7M	617.5M	780.6M	236.9M
Other Non-Current Liabilities	12.7M	21.0M	21.2M	21.3M	30.5M
Total Non-Current Liabilities i	2.5B	3.8B	3.9B	4.0B	2.1B
Total Liabilities i	3.5B	4.7B	4.7B	4.9B	2.7B
Equity
Common Stock i	4.4B	4.5B	4.5B	4.7B	2.0B
Retained Earnings i	2.5B	2.1B	1.9B	2.0B	1.9B
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	6.6B	6.3B	6.1B	6.5B	3.9B
Key Metrics
Total Debt i	2.2B	3.4B	3.2B	3.3B	1.8B
Working Capital i	978.6M	1.9B	1.1B	956.8M	633.8M

Balance Sheet Composition

Steris plc Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income i	616.1M	380.1M	105.8M	242.9M	396.9M
Depreciation & Amortization i	476.2M	565.2M	552.9M	553.1M	219.2M
Stock-Based Compensation i	57.4M	56.5M	39.0M	57.7M	26.0M
Working Capital Changes i	27.6M	-186.0M	-228.0M	-132.9M	9.1M
Operating Cash Flow i	1.1B	908.0M	266.3M	687.0M	679.7M
Investing Activities
Capital Expenditures i	-360.9M	-352.9M	-347.4M	-285.8M	-238.7M
Acquisitions i	760.4M	-536.8M	-35.9M	-380.7M	-908.7M
Investment Purchases i	-10.8M	-1.5M	0	0	-4.4M
Investment Sales i	0	3.9M	0	0	-
Investing Cash Flow i	388.8M	-887.4M	-383.3M	-666.6M	-1.2B
Financing Activities
Share Repurchases i	-211.3M	-11.8M	-308.6M	-55.8M	-14.6M
Dividends Paid i	-219.9M	-200.6M	-183.5M	-163.2M	-133.8M
Debt Issuance i	-	0	0	2.0B	550.0M
Debt Repayment i	-1.2B	-60.0M	-247.9M	-1.4B	-35.0M
Financing Cash Flow i	-1.6B	-95.7M	-500.5M	105.8M	318.9M
Free Cash Flow i	778.0M	612.9M	395.0M	397.2M	450.4M
Net Change in Cash i	-112.1M	-75.0M	-617.6M	126.2M	-155.6M

Cash Flow Trend

Steris plc Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 37.17

Forward P/E 24.60

Price to Book 3.47

Price to Sales 4.34

PEG Ratio 1.71

Profitability Ratios

Profit Margin 11.61%

Operating Margin 17.85%

Return on Equity 9.74%

Return on Assets 6.22%

Financial Health

Current Ratio 2.22

Debt to Equity 29.68

Beta 0.96

Per Share Data

EPS (TTM) $6.60

Book Value per Share $70.63

Revenue per Share $56.59

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
ste	24.2B	37.17	3.47	9.74%	11.61%	29.68
Abbott Laboratories	231.4B	16.68	4.58	30.93%	32.43%	26.50
Boston Scientific	158.9B	63.82	7.08	11.55%	13.55%	53.09
Stryker	150.0B	52.10	7.08	14.25%	12.25%	80.83
Medtronic plc	119.2B	25.66	2.49	9.74%	13.63%	59.44
Edwards Lifesciences	47.9B	33.87	4.51	15.53%	72.96%	6.62

Financial data is updated regularly. All figures are in the company's reporting currency.